首页> 外文会议>International Conference on Optics in Health Care and Biomedical Optics;Chinese Optical Society;Society of Photo-Optical Instrumentation Engineers;Tsinghua University >Multiphoton imaging of normal breast lobules, pleomorphic invasive lobular carcinoma, and classic invasive lobular carcinoma
【24h】

Multiphoton imaging of normal breast lobules, pleomorphic invasive lobular carcinoma, and classic invasive lobular carcinoma

机译:正常乳腺小叶,多形浸润性小叶癌和经典浸润性小叶癌的多光子成像

获取原文

摘要

Pleomorphic invasive lobular carcinoma (pILC) is a distinct morphological variant of invasive lobular carcinoma (ILC),which is more aggressive than classic invasive lobular carcinoma (cILC) with worse overall prognosis. It is critical todistinguish between pILC and cILC for management and treatment of patients. Multiphoton microscopy (MPM),basedon two-photon excited fluorescence (TPEF) and second harmonic generation (SHG), produces subcellular resolutionimages to show detailed information on structure and cell morphology of tissue sections without staining. In this work,MPM was introduced for label-free identification of normal breast lobules, pILC and cILC, which is consistent withhaematoxylin and eosin (H&E) staining. Furthermore, analysis of nuclear area is used to quantitatively reflect theircytological characteristic. These results demonstrate that, MPM has the ability to distinguish between normal breastlobules, cILC, and pILC by histopathological features, which can provide additional indicators to determine adequatetreatment strategies of patients with pILC for pathologists and surgeons. In the future, MPM may be used as a diagnostictool of lobular cancer into routine clinical use.
机译:多形性浸润性小叶癌(pILC)是浸润性小叶癌(ILC)的独特形态学变异, 它比经典的浸润性小叶癌(cILC)更具侵略性,但总体预后较差。至关重要的是 区分pILC和cILC来管理和治疗患者。基于多光子显微镜(MPM) 在双光子激发荧光(TPEF)和二次谐波(SHG)上产生亚细胞分辨率 这些图像可显示有关组织切片的结构和细胞形态的详细信息,而无需染色。在这项工作中, 引入MPM可以对正常乳腺小叶,pILC和cILC进行无标签鉴定,这与 苏木精和曙红(H&E)染色。此外,对核面积的分析被用来定量地反映其面积。 细胞学特征。这些结果表明,MPM具有区分正常乳房的能力。 小叶,cILC和pILC的组织病理学特征,可提供其他指标来确定适当的 病理学家和外科医生对pILC患者的治疗策略。将来,MPM可能会用作诊断 小叶癌的治疗工具已进入常规临床使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号